New hope for pancreatic cancer: novel drug combo enters final trial phase
Disease control
Recruiting now
This Phase 3 trial is testing whether a new formulation of the chemotherapy drug paclitaxel, given with gemcitabine, works better than the current standard treatment for metastatic pancreatic cancer. The study will enroll 416 adults who have not yet received treatment for their a…
Phase: PHASE3 • Sponsor: Shanghai Yizhong Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC